Key facts
- This page summarizes Thomas Hess's Form 3 filing for Hillstream BioPharma Inc. (THAR).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 11 Jan 2022, 20:46.
Thomas Hess - 11 Jan 2022 Form 3 Insider Report for Hillstream BioPharma Inc. (THAR)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- THAR
- Reported as of
- 11 Jan 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 11 Jan 2022, 20:46:19 UTC
- Prior SEC filing
- 01 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Randy Milby as Attorney-In-Fact for Thomas Hess
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Thomas Hess filed Form 3 for Hillstream BioPharma Inc. (THAR) on 11 Jan 2022.
Change
- Previous filing in this sequence was filed on 01 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney